D-Index & Metrics Best Publications
Biology and Biochemistry
Sweden
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 30,952 467 World Ranking 7628 National Ranking 146
Biology and Biochemistry D-index 84 Citations 27,916 380 World Ranking 2089 National Ranking 37

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in Sweden Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

Jan Hillert spends much of his time researching Multiple sclerosis, Genetics, Immunology, Internal medicine and Allele. His Multiple sclerosis study incorporates themes from Odds ratio, Central nervous system disease, Case-control study and Disease, Age of onset. In Immunology, he works on issues like CLEC16A, which are connected to CD226, Lymphocyte differentiation, Cellular immunity and Genetic architecture.

His research in Internal medicine intersects with topics in Endocrinology, Surgery and Pathology. Jan Hillert interconnects Molecular biology, Genome and Genotype in the investigation of issues within Allele. His Human leukocyte antigen research incorporates elements of Interleukin-7 receptor, Genome-wide association study, Linkage disequilibrium and Genetic association.

His most cited work include:

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (1970 citations)
  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (906 citations)
  • Variants conferring risk of atrial fibrillation on chromosome 4q25 (744 citations)

What are the main themes of his work throughout his whole career to date?

Multiple sclerosis, Immunology, Internal medicine, Genetics and Human leukocyte antigen are his primary areas of study. His Multiple sclerosis study also includes

  • Odds ratio and related Logistic regression,
  • Cohort and related Expanded Disability Status Scale. His Peripheral blood mononuclear cell research extends to Immunology, which is thematically connected.

His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology. His Genetics research focuses on Gene, Haplotype, Allele, Genetic predisposition and Single-nucleotide polymorphism. His studies in Allele integrate themes in fields like Locus, Genetic association and Genotype.

He most often published in these fields:

  • Multiple sclerosis (76.28%)
  • Immunology (27.20%)
  • Internal medicine (27.40%)

What were the highlights of his more recent work (between 2018-2021)?

  • Multiple sclerosis (76.28%)
  • Internal medicine (27.40%)
  • Cohort study (7.36%)

In recent papers he was focusing on the following fields of study:

Jan Hillert mainly investigates Multiple sclerosis, Internal medicine, Cohort study, Cohort and Disease. Multiple sclerosis is a subfield of Immunology that Jan Hillert studies. His work carried out in the field of Internal medicine brings together such families of science as Neurology, Oncology and Rituximab.

His biological study deals with issues like Disability pension, which deal with fields such as Pediatrics and Sick leave. His research integrates issues of Randomized controlled trial and Proportional hazards model in his study of Cohort. As a part of the same scientific study, Jan Hillert usually deals with the Disease, concentrating on Virus and frequently concerns with Haplotype, Etiology and Serology.

Between 2018 and 2021, his most popular works were:

  • Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. (120 citations)
  • Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. (46 citations)
  • Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. (32 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

His primary areas of study are Multiple sclerosis, Internal medicine, Expanded Disability Status Scale, Cohort study and Neurology. His Multiple sclerosis research is included under the broader classification of Immunology. The study incorporates disciplines such as Endocrinology, Cognition and Oncology in addition to Internal medicine.

His work in Expanded Disability Status Scale tackles topics such as Retrospective cohort study which are related to areas like Cohort, Natural history and Population based cohort. While the research belongs to areas of Odds ratio, Jan Hillert spends his time largely on the problem of Logistic regression, intersecting his research to questions surrounding Genetic predisposition, vitamin D deficiency, Quality of life, Vitamin D and neurology and Physiology. Jan Hillert has researched Epstein–Barr virus in several fields, including Autoimmune disease, Human leukocyte antigen, Etiology and Haplotype.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)

2667 Citations

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)

1112 Citations

Variants conferring risk of atrial fibrillation on chromosome 4q25

Daniel F Gudbjartsson;David O Arnar;Anna Helgadottir;Solveig Gretarsdottir.
Nature (2007)

983 Citations

Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek.
Neurology (2005)

959 Citations

The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm

Anna Helgadottir;Gudmar Thorleifsson;Kristinn P Magnusson;Solveig Grétarsdottir.
Nature Genetics (2008)

816 Citations

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis

Frida Lundmark;Kristina Duvefelt;Ellen Iacobaeus;Ingrid Kockum.
Nature Genetics (2007)

598 Citations

HLA CLASS II-ASSOCIATED GENETIC SUSCEPTIBILITY IN MULTIPLE SCLEROSIS : A CRITICAL EVALUATION

Olle Olerup;Jan Hillert.
Tissue Antigens (1991)

595 Citations

Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation.

Vilmantas Giedraitis;Bing He;Wen-Xin Huang;Jan Hillert.
Journal of Neuroimmunology (2001)

586 Citations

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.

Daniel F Gudbjartsson;Hilma Holm;Hilma Holm;Solveig Gretarsdottir;Gudmar Thorleifsson.
Nature Genetics (2009)

539 Citations

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

G. Comi;V. Martinelli;M. Rodegher;L. Moiola.
The Lancet (2009)

520 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jan Hillert

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 147

Jorge R. Oksenberg

Jorge R. Oksenberg

University of California, San Francisco

Publications: 132

George C. Ebers

George C. Ebers

University of Oxford

Publications: 122

Stephen Sawcer

Stephen Sawcer

University of Cambridge

Publications: 110

David A. Hafler

David A. Hafler

Yale University

Publications: 109

Tomas Olsson

Tomas Olsson

Karolinska Institute

Publications: 109

Philip L. De Jager

Philip L. De Jager

Columbia University

Publications: 109

Stephen L. Hauser

Stephen L. Hauser

University of California, San Francisco

Publications: 101

Patrick T. Ellinor

Patrick T. Ellinor

Harvard University

Publications: 93

Gavin Giovannoni

Gavin Giovannoni

Queen Mary University of London

Publications: 90

Helmut Butzkueven

Helmut Butzkueven

Monash University

Publications: 90

Fredrik Piehl

Fredrik Piehl

Karolinska Institute

Publications: 85

Giancarlo Comi

Giancarlo Comi

Vita-Salute San Raffaele University

Publications: 85

Lisa F. Barcellos

Lisa F. Barcellos

University of California, Berkeley

Publications: 83

Manuel Comabella

Manuel Comabella

Autonomous University of Barcelona

Publications: 80

Ludwig Kappos

Ludwig Kappos

University Hospital of Basel

Publications: 78

Trending Scientists

Soura Dasgupta

Soura Dasgupta

University of Iowa

Mohammad R. Ehsani

Mohammad R. Ehsani

University of Arizona

Quli Fan

Quli Fan

Nanjing University of Posts and Telecommunications

Michael Lovett

Michael Lovett

Washington University in St. Louis

Marie-France Bader

Marie-France Bader

Centre national de la recherche scientifique, CNRS

Huaijun Zhou

Huaijun Zhou

University of California, Davis

Darryl A. Knight

Darryl A. Knight

University of Newcastle Australia

Juan Ferré

Juan Ferré

University of Valencia

David J. Penman

David J. Penman

University of Stirling

Dean A. Hegg

Dean A. Hegg

University of Washington

Anthony J. Dore

Anthony J. Dore

University of Manchester

Francine M. Benes

Francine M. Benes

Harvard University

Eus J.W. Van Someren

Eus J.W. Van Someren

Vrije Universiteit Amsterdam

Michel J. Tremblay

Michel J. Tremblay

Université Laval

Ryan J. Lennon

Ryan J. Lennon

Mayo Clinic

Lance S. Weinhardt

Lance S. Weinhardt

University of Wisconsin–Milwaukee

Something went wrong. Please try again later.